INS and Insulin resistance: ► Oral or intravenous delivery of NButGT increases O-GlcNAc levels in all tissues assayed ► Various rodent models of insulin resistance were studied using NButGT ► Inhibition of OGA does not perturb insulin sensitivity or alter glucohomeostasis ► Provides framework for future studies examining the O-GlcNAc modification in vivo